PRESTO P2X Receptors as Therapeutic Opportunity an EU COST Action. Understanding the role of P2XRs in inflammatory, infectious, neurologic and oncologic diseases and fostering the development of P2XR-targeting therapies. Read more
P2X REceptorS as Therapeutic Opportunity

Action Challenge

PRESTO’s primary aim is to accelerate European progress towards a better understanding of the role of P2XRs and eATP in the pathogenesis of inflammatory, infectious, neurologic and oncologic diseases and to foster the development and translation to the clinics of P2XR-targeting therapies.

The Consortium

  • PRESTO has brought together 167 members from 28 different countries.

  • All participants are working together towards a common goal, utilizing their skills and expertise to drive the project forward.

  • The project has a strong and diverse team that is working towards advancing research and achieving its objectives.

  • Whether as a leader of a working group or as a coordinator of grant awarding, each person is making PRESTO a success!

Funded by
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
Status in June 2023

Women Scientists

Young Investigators